Skip to Main Content

Paper Details

A combined computational and functional approach identifies IGF2BP2 as a driver of chemoresistance in a wide array of pre-clinical models of colorectal cancer.
Mol Cancer
1
2023
Author NameAffiliation
Marie-Laure YaspoMax Planck Institute for Molecular Genetics
Johannes HaybaeckDiagnostic & Research Center for Molecular Biomedicine, Institute of Pathology, Medical University of Graz
Johannes HaybaeckInstitute of Pathology, Medical University of Innsbruck
  • 1 - 3

Datasets

Release 1.2